Bristol Myers Squibb says it will buy drug developer RayzeBio for about $4.1 billion.

Share:
More In Business
Top Dining Out Trends This Summer
OpenTable CEO joins Cheddar to discuss this summer's top restaurant trends, how best to make a reservation and what perks you can now get on the app. Watch!
Load More